Nexentis Technologies Inc. (NXTS)
NASDAQ: NXTS · Real-Time Price · USD
4.735
-0.105 (-2.17%)
At close: Apr 28, 2026, 4:00 PM EDT
4.466
-0.269 (-5.68%)
After-hours: Apr 28, 2026, 7:50 PM EDT
Nexentis Technologies Employees
As of December 31, 2024, Nexentis Technologies had 5 total employees, including 3 full-time and 2 part-time employees. The number of employees increased by 2 or 66.67% compared to the previous year.
Employees
5
Change (1Y)
2
Growth (1Y)
66.67%
Revenue / Employee
n/a
Profits / Employee
-$800,800
Market Cap
3.46M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Nutrien | 24,700 |
| The Mosaic Company | 13,249 |
| ICL Group | 13,007 |
| FMC Corporation | 5,500 |
| The Scotts Miracle-Gro Company | 5,200 |
| CF Industries Holdings | 2,900 |
| Bioceres Crop Solutions | 751 |
| American Vanguard | 739 |
NXTS News
- 2 months ago - N2OFF, Inc. Provides Early Warning Disclosure - TheNewswire
- 3 months ago - In Spaceflight Conditions: N2OFF‘s MitoCareX Bio Highlights Co-Founder's Innovative Research on Mitochondrial Carriers in Microgravity and Cosmic radiation Conditions - GlobeNewsWire
- 3 months ago - N2OFF: MitoCareX Bio Announces Positive In Vitro Results from Its Mitochondrial Carrier Small Molecule Platform - GlobeNewsWire
- 3 months ago - N2OFF: MitoCareX Bio Spotlights Co-Founder's Pioneering Research on Mitochondrial Carriers in Spaceflight Stress Conditions - GlobeNewsWire
- 4 months ago - N2OFF Advances $340,000 Payment to Gain Better Terms in Flag Solar Energy Initiative, Reflecting Approximately an Additional $1.7 Million in Project Profit Stake - GlobeNewsWire
- 4 months ago - N2OFF Accelerates European Renewable Energy Momentum with Major De-Risking Milestones and Approximately $1.69 Million Value Unlock in Germany and Italy - GlobeNewsWire
- 5 months ago - N2OFF: MitoCareX Identifies Hit Compounds and Targets Preclinical Candidate Nomination - GlobeNewsWire
- 6 months ago - N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers - GlobeNewsWire